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ABSTRACT
Many classes of transcriptional regulatory proteins are known to function in both
cell proliferation and differentiation. Runx1 proteins one such family of transcription
factors, plays critical roles in hematopoiesis, osteogenesis and leukemogenesis
and act as promoter organizers that cooperate with other transcription factors such
as Ets-1 in the regulation of gene activation or repression. Genes that are
regulated by the Runx1-Ets1 complex, frequently have multiple, adjacent
consensus binding sites in their promoters. I have investigated a similar interaction
in developing fly eye. Lozenge (DmRunx1) and Pointed P2 (DmEts-1) cooperate to
upregulate expression of prospero, which has multiple Lz and Ets binding sites.
Prospero protein is essential for establishing R7 cell fate in the developing eye.
Site directed mutagenesis and yeast two hybrid assay was employed to assess
critical residues involved in the Lz-Pnt P2 interaction. Results unequivocally
demonstrate that Lz-Pnt P2 interaction occurs independent of their DNA binding
sites, implying that the interaction is not mediated by their mutual interaction with
DNA. Site directed mutation reveals reduced Lz-Pnt P2 interaction, indicating the
relevance of altered amino acids for the contact between the proteins.
Interestingly, akin to AML1 (Runx1), lz is also spliced over the domain important for
interaction with Ets-1 proteins. Based on the results obtained in this study, we
suggest that splicing produces variants that allow these proteins to either interact
with Ets-1 and other proteins to transactivate other genes or to work independently
in a divergent role in developmental process.
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1INTRODUCTION
A fundamental regulatory problem for the cell biology of metazoan
development and evolution is the balance between proliferation and
differentiation. These processes are often thought of as antagonistic and must be
tightly regulated to allow both processes to operate normally during development.
The cellular mechanisms that underlie this regulation are fundamentally
important in determining the size, shape, complexity and health of multicellular
organisms (Coffman, 2003). Transcriptional regulatory proteins directly control
the expression of genes in response to specific physiological/developmental
signals, and thus lie at the core of every developmental regulatory mechanism.
Many classes of transcriptional regulatory proteins are known to function in
coordinating both cell proliferation and differentiation. Well known examples
include homeobox proteins and CCAAT transcription factors like C/EBP and CBF
(Ramji et al., 2002; Lekstrom-himes et al., 1998; Alam et al., 1992). A particularly
intriguing family of transcription factors is defined by the runt domain (Runx),
which is apparently a metazoan invention involved in controlling the proliferation
and differentiation of cells during development (Rennert et al., 2003).
The runt box is a highly conserved DNA binding and protein-protein
interaction domain that defines the Runx family of transcription factors. The runt
domain derives its name from the Drosophila regulatory gene runt, which was
discovered in genetic screen and named for its mutant phenotype, reflecting its
role as a primary “pair rule gene” in establishing the pattern segments in the
embryo (Gergen and Butler, 1988). Subsequently runt was shown to have
2additional genetic functions in sex determination and neurogenesis (Duffy and
Gergen, 1991; Duffy et al., 1991). A second Runx gene found in Drosophila is
lozenge (lz). It was discovered genetically through its requirement in cell
patterning in the eye and was shown to have additional roles in cell fate
specification during hematopoesis (Green et al., 1990; Rizki et al., 1981;Daga et
al., 1996; Flores et al., 1998).
There are three Runx genes in mammals. Runx1 is required for definitive
hematopoiesis and is a frequently mutated gene in human leukemia (Westendorf
and Hiebert, 1999), Runx2 is required for osteogenesis and is associated with
cleidocranial dysplasia (reviewed in Otto et al., 2002), and Runx3 controls
neurogenesis in dorsal root ganglia and cell proliferation in gastric epithelium,
and is frequently deleted or silenced in human gastric cancer (Li et al., 2002). In
addition to those already mentioned, runx genes have been recently discovered
and characterized in C. elegans (Nam et al., 2002), as well as in a variety of
vertebrates including zebrafish (Kalev-Zylinska et al., 2002; Kataoka et al., 2000)
and Xenopus (Tracey et al., 1998).
Runx transcription factors and the developmental balance
Studies using mammalian systems indicate that Runx proteins have
essential functions in both cell proliferation and differentiation. As a result of
these dual functions, Runx proteins are both proto-oncogenes and tumor
suppressors. Thus, a central question concerning the cell biology of Runx
proteins is how are the opposing functions of this class of transcription factors
regulated during development? At least part of the solution to the above
3predicament lies in the alternate splicing of the Runx proteins. The best evidence
to date regarding the potential function of the different splice variants comes from
experimental work of Tanaka et al., (1995). They showed that overexpression of
the short Runx1/p26 isoform (AML1a), which lacks much of the C-terminus and
hence, the transactivation domain present in longer isoform Runx1/p49 (AML1b),
blocks differentiation and promotes proliferation of a murine cell line, whereas
AML1b has the opposite effect of promoting differentiation and arresting
proliferation (Tanaka et al., 1995). In another study, overexpression of isoform
AML1d in embryonic stem cells inhibited the ability of these cells to form
teratocarcinomas in vivo when transplanted into mice, while similar
overexpression of AML1b failed do so (Ben Aziz-Aloya et al., 1998).
These studies suggest that differentially spliced Runx proteins play
opposing roles. In addition, the cellular decision of whether to continue
proliferating or to differentiate is affected by the relative levels of expression of
the different variant. This has led to corollary hypothesis that acute myleogenous
leukemia associated with runx1 translocations is fundamentally a disease of
gene splicing, which results from an imbalance between the proliferation-specific
and differentiation-specific Runx isoforms (Van der Reijden et al., 1996, Miyoshi
et al., 1995).
It is therefore important to determine how phylogenetically widespread the
differential splicing phenomenon is and how it is regulated during development.
4Runx1 proteins share common domains
The signature of this protein family is a 128 amino acid motif called the
runt domain. The runt domain typically lies near the N-terminus of the protein.
Structural analysis revealed that this domain forms an Ig fold, which is also the 3-
dimensional structure of the DNA-binding domain in transcription factors such as
P53, NF-kB, NFAT, STAT, and the T-box proteins (Berardi et al., 1999). The
sequence similarity between runt domains of distantly related species is
remarkable. The domain in addition to playing a role in DNA binding also
contains an ATP binding site (Crute et al., 1996, Kagoshima et al., 1993). The
identity within the runt domain is 79% for AML1b and Lz and 96% for AML1b and
mouse homolog PEBP2aB2. Additionally, amino acids at the C-terminal end of
the runt domain along with a stretch of another 10 amino acids constitute a
region responsible for nuclear localization of the proteins (Kanno et al., 1998).
The C-terminal halves of Runx1 proteins tend to be rich in proline, serine and
threonine and function in activation and repression of transcription. Finally every
known runx1 gene except one encodes a protein that terminated with the amino
acid sequence VWRPY, which functions as a recruitment motif for the
Groucho/TLE family of co-repressors. Derived from the sequence homology
between the proteins, an illustrative figure indicating various functional regions is
shown (Figure 1).
The mouse Runx1 protein PEBP2aB is also alternatively spliced and two
isoforms have been identified and characterized by Bae et al., (1994). Their
protein products are identical except for the deletion of the 64 amino acids long
exon immediately C-terminal to the runt domain. The shortened isoform is
5referred to as PEBP2aB2. Electrophoretic mobility shift studies done in presence
of CBFb (a subunit required for DNA binding of the Runx proteins) showed that
the full length PEBP2aB1 bound DNA with a different affinity than the shorter
isoform. Both isoforms were able to transactivate a CAT reporter, but the shorter
form had a decreased ability to do so (Bae et al., 1994).
Interaction with Ets-1 factors
The DNA binding activity of Runx1 is regulated in cis by amino acid
sequences in the C-terminal of the protein that inhibit DNA binding by the runt
domain. It was recently shown that interaction of Runx1 protein (Human AML1b
and Mouse PEBP2aB2) with ETS-1 transcription factor on adjacent sites of T-cell
beta chain enhancer displaces the negative regulatory domains of both proteins,
facilitating DNA binding (Kim et al., 1999; Gu et al., 2000). Ets-1 and AML1
cooperate in the regulation of T cell receptor and play critical roles in
hematopoiesis and leukemogenesis (Wotton et al., 1994; Giese et al., 1995; Sun
et al., 1995).
In mouse, the two PEBP2aB isoforms interact with Ets-1 cooperatively to
bind DNA in electrophoretic mobility shift assays, the shorter aB2 showing a
stronger cooperativity than aB1 in presence of increasing amounts of Ets–1 (Kim
et al., 1999). Surprisingly, only the full-length form showed cooperative
transactivation with Ets-1. The expression of both isoforms was increased in Ha-
Ras transformed fibroblasts, suggesting that Ras acts upstream of PEBP2aB
(Bae et al., 1993).
6The Ets family of transcription factors, named for the proto-oncogene E26
includes >20 proteins. Drosophila homologs of this family are YAN, Pointed (PNT
P2) and ELG. The common feature of ETS proteins is a domain of 85 amino acid
residues called the Ets domain, which is structured helix-turn-helix motif
responsible for their binding to specific sequences and is 95% identical to PNT
P2 protein (Klambt et al., 1993). Human c-Ets-1 protein and Drosophila Pointed
P2 protein belong to a subset of Ets family of transcription factor called Ets-1,
regions of similarity between the two proteins are illustrated in the figure 2.
The cooperative effect of the two protein families suggests that one
function of the negative regulatory domains may be to favor DNA binding of the
longer Runx1 variant to a specific subset of Runx1 target sequences. In fact, a
common theme for runx gene regulation is context-dependency through
functional, and, in this, case physical interaction with Ets-1 proteins. Several
functional Runx1 binding sites in DNA flanked by Ets-1 site are known (Wotton et
al., 1994; Sun et al., 1995). Depending on the specific context of the regulatory
region with which they interact Runx1 proteins can function either as activators or
repressors.
Significance of interaction: Runx1 proteins and human health
The significance of the protein binding domains found in Runx1 and their
interaction with Ets-1 is further underscored by the fact that leukomogenic
versions of aB1 (AML1) and Ets-1 bear mutations that should affect the
regulation of DNA binding and protein complex formation. Several translocations
of the aB1 (AML1) gene generating chimeric proteins, such as AML1/ETO
7(MTG8) and AML1/EV-1, have been found in human myeloid leukemia, all of
which cause a deletion of the ‘negative regulatory DNA binding domain’ and Ets-
1 interaction surface (Ito and Bae, 1997). Similarly, the viral version of Ets-1
contained in leukemogenic chicken virus E26 bears a mutation in the inhibitory
C-terminal helix. It is also constitutively activated and does not require a cofactor
for DNA binding (Hagman et al., 1992; Lim et al., 1992). The escape from the
regulatory mechanisms that have evolved to tightly control the DNA binding
activity of these transcription factors may thus be a major factor contributing to a
leukemogenic potential of their mutant versions.
Drosophila orthologs of Runx1 and Ets-1 are expressed during eye
development
Both lz and pnt P2 are required for normal eye development in Drosophila
(Green and Green, 1956; Green, 1990; Brunner et al., 1994; O’Neill et al., 1994).
This creates an advantage for studying Runx1/Ets-1 function in that the fly eye is
a dispensable organ and that the developing fly eye is a well-studied model,
affording a tissue-based system for analyzing these factors. Interestingly, like
Runt1, the Lz protein is involved in several developmental processes, including
eye, antennal (smell), and tarsal claw development (taste), hematopoiesis, and
female fertility (Green and Green, 1956; Stocker et al., 1993; Batterham et al.,
1996; Green et al., 1949).
The developing eye
The compound eye of the fruit fly is composed of about 800 unit eyes
referred to as ommatidia (Ready et al., 1989). Each ommatidium contains an
identical set of cells that include eight photoreceptor neurons (R1-R8), four lens-
8secreting cone cells, pigmented supporting cells, and a mechanosensory hair
nerve group. The compound eye is derived from the eye imaginal disc, a simple
monolayer epithelium created during embryogenesis. The disc remains
unpatterned until the third larval instar stage of development (approximately 4
days after hatching), at which time cell fate determination begins along posterior
edge (Wolff and Ready, 1993). The onset of differentiation is marked by the
passage of a morphogenetic furrow that initiates patterning of cell fates, first
establishing photoreceptor neuron R8 (Baker and Rubin, 1989; Ma et al., 1993;
Heberlein et al., 1993; Jarman et al., 1995; Brown et al., 1995). Cell R8 in turn
recruits photoreceptor neurons R3 and R4, which together form the five-cell pre-
cluster (Wolff and Ready 1993). Unfated cells posterior to the five-cell pre-cluster
undergo a synchronous round of mitosis, repopulating the eye epithelium with
undifferentiated cells that are needed recruitment of additional cells (Ready et al.,
1976; Wolff and Ready, 1991). Photoreceptor cells R1, R6, and R7 then join the
cluster, followed by the progressive recruitment of the four cone cells, and finally,
the three types of pigment cells and the hair nerve group (reviewed by Wolff and
Ready, 1993). A figure depicting this recruitment of cells is shown in figure 3.
The R1, R6, R7 and cone cells share a common developmental potential
and are called the “R7 equivalence group”, as they all are competent to gain the
R7 cell fate (Hiromi et al., 1993). Normally only one of them achieves R7 fate
(reviewed in Dickson 1995). Cone cells are prevented from becoming R7-like
because they do not contact R8, whose expression of BOSS protein leads to
contact activation of the Sevenless tyr-K receptor protein in R7 precursors
9(Tomlinson and Ready, 1987; Zipursky and Rubin 1994). R1/R6 cells are
normally prevented from becoming R7 by the expression of seven-up (sev)
(Mlodzik et al., 1990). In turn, activation of Bar, which encodes homeobox
proteins expressed in R1/6 cells, works to guide the differentiation of those cells
(Higashijima et al., 1992). In addition, Prospero (Pros), a homeodomain protein
for R7 and cone cells (Kauffman et al., 1996; Flores et al., 1998) and Dpax-2, the
Drosophila Pax-2 homolog is required for development of cone cells (Flores et
al., 2000).
In the developing retina, Lz is expressed in a subset of cells during late
third larval instar (Crew et al., 1997; Flores et al., 1998). Transcriptional
expression is seen in undifferentiated cells behind the morphogenetic furrow, a
developmental marker for retinal differentiation. A few hours later in
development, lozenge expression is elevated in three neuronal precursor cells as
they establish their fate as R1, R6, and R7. Later, elevated expression is
detected in the four cone cells, and the pigment cells of each facet. Genetic
analysis has revealed that Lz positively regulates Bar in R1 and R6, and DPax-2
in cone cells, and pros in R7 and cone cells (Figure 4). Expression of these
factors is lost in animals mutant for Lz (Daga et al., 1996; Crew et al., 1997).
Conversely, Lz negatively regulates seven-up expression (Daga et al., 1996;
Crew et al., 1997). Loss of function mutations in lz allow svp to be ectopically
expressed in the cone cells precursors, causing them to adopt neuronal fates.
Thus, Lz protein is expressed early and in undifferentiated cells and coordinately
regulates various transcription factors.
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EGF receptor in eye development and MAP kinase activation
In eye development, Ras signaling is initiated by activation of Drosophila
EGF receptor (DER) by its ligand Spitz (Freeman et al., 1997). Spitz is a local
signal, sent from neighboring neurons in the process of differentiation. The R7
photoreceptor is unique in that it also requires Ras activation by a second
receptor tyrosine kinase, Sevenless (Fortini et al., 1992). Boss is the cell surface
membrane protein on the R8 photoreceptor that activates Sevenless and is
internalized with Sev RTK into R7 cell (Cagan et al., 1992). Ras activation leads
to changes in gene expression controlled by phosphorylation (Brunner et al.,
1994; O’Neill et al., 1994; Rebay and Rubin 1995; Wasylyk et al., 1997).
Research on the Ras pathway in the eye has deduced a developmental
switch consisting of two antagonist Ets transcription factors, Yan and Pointed
(Pnt). Yan is expressed in undifferentiated cells behind the furrow and its
expression is dramatically reduced as cells differentiate (Lai and Rubin, 1992).
This reduced expression is a result of phosphorylation by MAP kinase. Yan
directly represses Prospero expression in developing R7 (Xu et al., 2000) and
cone cells and D-Pax2 expression in cone cells (Flores et al., 2000). Pnt P2 is a
transcriptional activator, and competes with Yan for cognate binding sites on both
prospero  and D-Pax2 enhancers. Pointed is also expressed in the
undifferentiated cells in and behind the furrow. Phosphorylation by MAP kinase
allows the activation of isoform Pnt P2, hence it ability to transactivate its targets
(refer to Figure 5)(Brunner et al., 1994; O’Neill et al., 1994). Ectopic expression
of Yan inhibits Prospero expression (Xu et al., 2000), D-Pax2 expression (Flores
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et al., 2000), and Lz expression (Behan et al., 2002) and thus prevents
differentiation (Rebay et al., 1995).
Lozenge as a survival factor
Recently, lz in addition to its known role in gene regulation of cell-specific
transcription factors has been implicated in repression of cell death mechanisms
(Siddall et al., 2003). The early expression of Lz protein in undifferentiated cells
has been documented. These unfated, G1 arrested cells would normally be
instructed to undergo cell death (reviewed in Baker et al., 2001). However, in eye
development, these cells must survive for several hours before other
mechanisms that control fate determination, such as EGF receptor activation, Lz
control over genes including seven-up and Bar, and activation of the sevenless
signaling cascade can take over. During this time, the default pathway must be
repressed. Studies done by Siddall and co-workers, show that initial function of lz
is to create a permissive environment, allowing cells to survive long enough to
allow the R7 equivalence group cells to establish their fates.
Lozenge is alternatively spliced
The lz gene has many similarities to AML1. Not only is the regulation of
gene expression under the Ras/MAPK signaling pathway conserved from flies to
vertebrates but the Lz protein also shows a strong homology to the conserved
runt domain and other regions associated with function including a nuclear matrix
signal, transactivation nuclear localization, ATP binding etc. Like the human AML
1 and mouse PEBP2aB, the spectrum of lozenge phenotypes includes sensory
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neuron and blood cell defects. Also, in parallel to the mutually exclusive roles of
cell proliferation and differentiation of Runx1 proteins, recent studies on lz have
shown that Lz protein too has more than one role to play in the development.
Aside from its role in determining the fates of a number of neuronal and non-
neuronal cells by regulating the expression of multiple fate-determining
transcription factors, it is required to contribute to the repression of cell death
mechanism. Thus, in the undifferentiated cells it also acts as a survival factor
allowing the undifferentiated cells to proliferate until they achieve their respective
fates.
Interestingly, Flores and co-workers showed a partial rescue of lz null
mutant by expressing a full-length lz cDNA behind its native promoter and eye-
specific enhancer (Flores et al., 1998). The result was dramatic, yet paradoxical.
While the adult eye appeared normal, the pattern of Lz expression in developing
eye changed considerably. Lz protein was still found in the undifferentiated cells,
but it could no longer be detected in the differentiated cells. These rescued flies
where probed in John Pollock’s laboratory to examine the protein expression of
Prospero, Runt and Bar showed expression pattern similar to that in wild type.
The same flies when labeled with Lz antibody showed expression only in the
undifferentiated cells. Contrary to expression in wild type, no expression was
found in R1, R6, R7, cone and pigment cells (Flores et al., 1998). The success of
the rescue led Flores and co-workers to conclude that Lz expression was only
required in undifferentiated cells. However, experimental work from John
Pollock’s laboratory indicated otherwise. In comparison with undifferentiated
13
cells, Lz protein expression was more pronounced in differentiated cells (Behan
et al., 2001).
Drawing from the above study and similarities between Lz and other
Runx1 protein, Charles Nichols in John Pollock laboratory worked on clones
identified by the Banerjee laboratory and identified a splice variant that lacked
exon V of the full length transcript (Nichols, 1997). Further, Kris Behan in the
same lab identified the same two transcripts by doing RT-PCR on RNA derived
from eye-imaginal disc. The full-length lozenge transcript is 3471 nucleotides,
encodes six exons and is referred as lz-c 3.5.  The difference in size was found
to be about 360 nucleotides, the expected size of exon V. Sequencing of the
products revealed exon V was precisely removed in alternative isoform, with an
amino acid change form S to T at the splice interface. It is referred to as lzD5.
A plausible explanation then for anomalies observed for Flores rescued
flies is that since the antibody used in the above studies is made to a peptide
sequence in exon VI, the protein detected in wild type was LzD5 (Behan, 2001).
Functional homology between lzD5 and PEBP2aB2. Exon V encodes a
putative interaction domain
Two functions have been assigned to the shorter isoform of murine Runx1
gene (PEBP2aB). PEBP2aB2 lacks the exon C-terminal to runt domain.
Runx1/AML1/PEBP2aB auto-inhibits DNA binding by virtue of a negative
regulatory region for DNA binding (NRDB) (Ito, 1999), a region that lies C-
terminal to the Ets-1 interaction domain and extends beyond the alternatively
spliced exon boundary. Auto-inhibition is relieved by cooperative binding Ets-1
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(Gu et al., 2000; Kim et al., 1999). Also, Runx1/AML1/PEBP2aB heterodimerizes
with a beta partner CBFb/PEBPb to form core binding factor (CBF). The beta
partner does not contact the DNA directly, but changes the conformation of the
Runx1 proteins to increase its affinity for target DNA (Berardi et al., 1999;Golling
et al., 1996). When Runx1 is not associated with its beta protein it is rapidly
degraded (Huang et al., 2001).
It would be consistent with the Runx1 paradigm that Lz also auto-inhibits
DNA binding. Inhibition can be relived by two mechanisms. First, splicing out this
exon would alleviate inhibition and result in stable Lz protein. Second,
autoinhibition would be relieved by cooperative binding and stabilizing with Pnt
P2. Pnt P2 is expressed in undifferentiated cells behind the morphogenetic
furrow, but expression ceases about six hours later (Brunner et al., 1994). This
severely restricts the timing interval for Lz-Pnt P2 cooperativity. If full-length Lz
binds in absence of Pnt P2, it would be degraded. This model helps to explain
the presence of Lz protein in undifferentiated cells and loss of antibody staining
in differentiating cells of rescued flies (Behan, 2001). It is also reasonable to
deduce that full-length isoform is able to substitute for LzD5, if it ectopically
expressed as both forms share the canonical domains. However, in accordance
with the Runx1 paradigm the ectopically expressed binds DNA with less affinity
(Behan, 2001).
Further, sequence comparison between Lz and Runx1 proteins points to a
strong homology between Ets-1 interacting region in the Runx1/ AML1/PEBP2aB
and exon V in Lozenge.
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Lz-Pnt P2 interaction recapitulate Runx1-Ets-1 interactions
Prospero enhancer contains multiple binding sites for Lz and Ets factors
(Xu et al., 2000); the Lz-1 site and Ets-A site are seven base pairs apart
representing a potential Runt1-Ets composite motif. Prospero protein, expressed
in R7 and cone cells shows increased expression in R7 relative to cone cells as
the cells mature (Kauffmann et al., 1996). Previous in vitro studies indicate Yan
outcompetes Pnt P2 for binding sites on the prospero enhancer by 100-fold (Xu
et al., 2000). This work was recapitulated in vivo by Kris Behan in her doctoral
work by expressing a hyperstable form of Yan ACT via sevenless enhancer. This
allowed Yan expression to be targeted directly to subset of cells, including R7
and cone cells (Rebay and Rubin, 1995). Prospero expression was found to be
aberrant in R7 cells: the expression disappeared or decreased as the cells
matured. Lz expression was also found to be decreased in these flies (Behan et
al., 2002). Significantly, they also showed that ectopic expression of Lz tipped the
competition in favor of Pnt P2. This shift in the Yan/Pnt P2 competition is
strikingly similar to change in affinity that Ets-1 has for Mo-MLV enhancer in the
presence of Runx1/AML1/PEBP2aB (Goetz et al., 2000) and is consistent with
the model of Lz-Pnt P2 cooperativity.
Further support that sequences in exon V are important for prospero
regulation is supplied by mutant lzr9. This allele represents a large deletion in lz
locus, removing 254 amino acids of the C-terminal sequence, but retaining the
entire exon V. The adult eye was severely perturbed, resembling a lz null.
Surprisingly, at the cellular level, Prospero expression in lzr9 is normal in
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developing R7 cell. RT-PCR verified that the truncated lz transcript was
expressed in the tissue, and the entire exon V was included in the transcript.
Expression of both PEBP2aB and Lozenge are altered in a Ras background
Studies on Runx1 proteins in mammals also show that the cellular
decision of whether to continue proliferating or to differentiate is affected by the
relative levels of expression of the different variants of the protein (Coffman,
2003). There is compelling evidence that, similar to mammalian Runx1 proteins,
expression of both lozenge isoforms are sensitive to changes in Ras expression
(Behan, 2001). Because Lz acts downstream of the Ras signaling cascade
during eye development (Behan et al., 2002), experiments were done to see
whether a change in Ras activity alters Lz protein expression. This was achieved
by ectopically expressing the dominant negative Ras1N17, which competes with
native Ras product (Feig et al., 1988), resulting in cell fate alterations (Karim et
al., 1996). Ras1N17 was targeted to subset of cells in the developing eye using
the sevenless enhancer system. Ras pathway is responsible for activating the
Yan/Pnt P2 switch (O’Neill et al., 1994;Brunner et al., 1994). The dominant
negative Ras1 N17 limits this switching mechanism. Quantitative RT-PCR
revealed that both isoforms were downregulated in this Ras background.
The change in lz ratios is interpreted in two ways. One explanation
suggested is that in a given subset of cells, a change in regulation of splicing
occurred, which subsequently led to change in cell fate. Alternatively, it is
possible that lz isoform ratio is cell type specific and the proportion of these cells
changed.  The cells that overlap Ras1N17 and Lz are the R7 and cone cells and a
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~25% and 25-75% developmental failure was seen in these cells (Karim et al.,
1996; Matsuo et al., 1997; Behan, 2001). This model is consistent with findings
that ratios of Runx/AML isoforms are tissue/cell line specific.
Research goals
Runx proteins are evolutionarily well-conserved transcription factors that
are involved in essential aspects of the development of metazoan animals
ranging from fruit flies to humans. Genetic defects in any one of the three Runx
proteins in humans can cause severe diseases. Although much is known about
the functions and signaling pathways of the Runx proteins in mammals, there are
still gaps in our knowledge with regards to functions of Runx proteins in normal
development, diseases state and their regulation. The Drosophila genome
encodes two Runx proteins, Runt and Lozenge that share similar expression
patterns and biological functions with mammalian homologs, thus offering a
promising model for studying the functions and regulation of Runt proteins.
Clearly, the data reviewed in this chapter indicates that Lozenge, the
Drosophila homolog of Runx1/AML1, shares some of the functional features of
the Runx1 proteins. Both proteins have pleiotropic functions and can act as
activators or repressors of transcription through recruitment of additional
transcriptional modulators. Additionally, like Runx1 proteins, alternate splicing of
lozenge and relative levels of expression of isoforms may enable it to play
opposing roles in promoting proliferation and/ or differentiation. From Kris
Behan’s thesis it is also evident that the Runx1 paradigm of cooperation with Ets-
1 protein is recapitulated in developing fly eye (Behan, 2001). Her studies
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provide genetic data to show that Lz and Pointed P2, the Drosophila homolog of
Ets-1 protein, cooperate to regulate expression of prospero, which in turn
establishes R7 cell in ommatidium. However, evidence indicating a physical
interaction between Lz and Pnt P2 protein is lacking.
The goal of this research, therefore, is to provide molecular data that
corroborates this interaction. Furthermore, an effort is made to show that a
putative site of interaction exists in the alternatively spliced exon of lozenge,
which is essential for stabilizing this interaction. In order to identify protein-protein
interaction, a yeast two-hybrid system was used as it provided an appropriate
biological system for evaluating a physical interaction and its subsequent
functional characterization. In addition, the system aids us to overcome the
problem of getting pure proteins that would otherwise be an issue for lozenge, as
it is known to be toxic to numerous cell lines (personal communication with Dr.
John A. Pollock). However, in order to establish such a functional analyses, the
isolation of mutant protein specifically altered in their ability to interact with a
potential partner was critical. Thus, site directed mutagenesis experiments were
designed to generate lozenge protein with altered sites in exon V. These mutant
constructs also enable us to look more closely at the functionality of alternatively
spliced exon V and its role interaction. Verification of proteins by Western
analysis was done to strengthen the results. Furthermore, during the course of
this research, an attempt was made to delve deeper in to analyzing the
secondary structure of Lozenge and Pointed P2 proteins.
19
Figure 1: Diagrammatic representation of functional regions
in PEBP2aB and Lz isoforms.
The defining feature of the Runx1 protein, the Runt domain (yellow), functions in
DNA binding. ATP binding region lies in this domain represented by a red line.
Nuclear localization signals are also located in this domain. DNA binding ability of
proteins is regulated by a region adjacent to Runt domain termed the negative
regulatory region of DNA binding (NRDB/green) and tends to be rich in proline,
serine, threonine (PST). Region adjoining the NRDB is called the activation
domain (AD/pink) (Kanno et al., 1998). All proteins in this family (Lz and
PEBP2aB isoforms) terminate with amino acid sequence VWRPY (blue) that
functions as a recruitment motif for the Groucho/TLE family of co-repressors.
Region that helps in association with the nuclear matrix, distinct from nuclear
localization is represented by pink line. Blue lines represent the regions that are
responsible for interacting with Ets-1 factors. LzD5 and Pepb2aB2 (shown as
Pebp2aB2) are two isoforms of the Dm-Runx1, Lz and Mm-Runx1, Pebp2aB
respectively. Splicing in the proteins removes 64 amino acid exon immediately C-
terminal to the Runt domain in Peb2aB and 118 amino acids or exon V in Lz.
Splicing removes one of the Ets-1 interaction.
Amino acids number and boxes on the illustration represent the functional
domain and not the exon boundaries.
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Figure 2: Schematic illustration of the functional regions
in Ets-1 proteins.
A functional domain alignment between Dm-Pointed P2 and human Ets-1 family
factor, c-Ets-1 is shown. The PNT P2 domain (pink) distinguishes this subset of
Ets family and is contained within the regulatory domain of the Ets protein. DNA
binding Ets domain (yellow) is flanked by autoinhibitory domains (green). MAPK
phosphorylation site is marked (blue star). Blue lines represent three regions of
Ets-1 responsible for interacting with Runx1 family of proteins. Amino acids
numbers and regions do not represent exon boundaries.
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Figure 3: Progressive recruitment in Drosophila eye
development.
Differentiation of the eye imaginal disc begins during the third larval instar at the
posterior of the disc (bottom), and sweeps toward the anterior in a wave. The
front wave is referred to as morphogenetic furrow. Each row represents a
passage of approximately 1.5 hours time. Cells labeled yellow express Lozenge.
1. Cells in white are anterior to furrow, and are differentiated
2. Cells in the furrow express a number of markers. The first cell to specify a
fate is R8 neuron, represented here as a single blue circle. One row later
(approximately 1.5 hours later) the R2/R5 neuron pair has joined the R8. The
next row shows the photoreceptor pair R3/R4 joining the others, marking the
5-cell precluster.
3. Undifferentiated cells enter S phase in a synchronous round, depicted here as
mitotic cells in pink. These cells repopulate the epithelium
4. Photoreceptors R1/R6 join the precluster, followed by R7
5. Cone cells join groups of two, completing the cluster.
Blow up view of one ommatidium CC: cone cells. 1, 6, 7: Photoreceptor neurons
are shown in their stereotypical position.
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Figure 4: Lozenge regulatory pathway in eye development.
llustration of many known steps in the lz regulatory pathway as it is involved in
photoreceptor neuron development and in development of accessory cells. Once
Lz is activated, it in turn effects the expression of genes essential for correct
differentiation of cells in the such as Bar, svp, prospero, D-Pax2, Runt and others
(Daga et al., 1996; Crew et al., 1997; Flores et al., 2000; Xu et al., 2000; Behan
et al., 2002).
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Figure 5: Ras MAPK activation in R7 cell.
Left panel: In the undifferentiated cells, Yan (red octagons) represses prospero
by directly binding to Ets sites. The transcriptional activator Pointed P2 (green
squares) competes for the same DNA but with much less affinity. Lozenge (blue
circles) transcription is tempered by Yan, but not entirely repressed.
Right panel: DER and Sev are activated by their respective ligands Spitz and
BOSS, resulting in Ras1 stimulation. Ultimately, Yan and Pnt P2P2 are
phosphorylated but with opposite effects. Phosphorylated Yan is targeted for
degradation. Phosphorylated Pointed P2 binds to DNA with a higher affinity. Yan
repression of Lz is alleviated, and upregulation occurs by some other
mechanism. Upregulated Lz binds with Pnt P2 to mediate prospero transcription.
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METHODS AND MATERIALS
Overview
This chapter was written to clearly state the procedural steps of the
experiments and would serve as a resource to anyone attempting to investigate
protein–protein interactions. Generation of the mutant construct of lozenge will be
described first. This is followed by an outline of steps used for the construction of
fusion genes and detection of protein interactions by the Yeast Gal4 two hybrid is
elucidated. Finally, verification of proteins by Western blotting is outlined. The
solutions and media used for the experiments are described at the end of the
chapter.
Site directed Mutagenesis
In vitro site-directed mutagenesis is an invaluable technique for studying
protein structure-function relationships and gene expression, and for carrying out
vector modification. Several approaches that have been used before require
single-stranded DNA (ssDNA) as the template and are labor intensive or
technically difficult. Stratagene’s QuikChange site-directed mutagenesis kit
(Catalog #200516) allows site-specific mutation in virtually any double-stranded
plasmid, thus eliminating the need for subcloning into M13-based bacteriophage
vectors and for ssDNA rescue.
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Figure 6: Overview of the Quick Change XL site-
directed mutagenesis method
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Design of Primers
Mutagenic primers were designed for the lozenge gene that altered two
contiguous conserved amino acids between AML-1 and exon V. Exon V is
implicated in Ets interaction. The mutation was designed to alter the biochemical
properties of helix, the strong secondary structure present in Exon V. The
arginines were replaced by glutamic acid to reverse the charge completely
keeping the helix structure intact. Primers guidelines used were as follows
1. Both oligos contained the same mutation and anneal to the
same sequence on the opposite strand.
2. The desired mutation was flanked by unmodified sequence
on either side by 10-15 complementary bases.
3. Length of the primers was 36 nucleotides and the Tm was
approximately 10°C above extension temperature of 68°C.
4. Primers were PAGE purified and ordered from Integrated
DNA technology.
420 RPYIDGFPSTKALHELESLRRSAKVAAVTTAAAAAATAASAANAVAAAAAAVAVTPTGG 480
                       EESA
LOZENGE: 4 conserved sites are represented in red.
FORWARD PRIMER
SDMF= CTG GAG TCG CTT GAG GAG TCC GCC AAG GTG GCA GCG
Tm=75.6, length=36
REVERSE PRIMER
SDMR= CGC TGC CAC CTT GGC GGA CTC CTC AAG CGA CTC CAG
Tm=75.6, length=36
Table 1:Primers for Site directed Mutagenesis
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Mutant Strand Synthesis Reaction
Lozenge in pBluescript and Lozenge Exon V in pCRBlunt were used as
dsDNA template. Control and sample reaction of 50 µl were assembled as
follows:
Control Reaction Sample Reaction
5 µl of 10x reaction buffer
2 µl (10 ng) of pWhitescript control
template
1.25 µl (125 ng) of control primer#1
1.25 µl (125 ng) of control primer#2
1 µl of dNTP mix (10 mM)
3 µl of QuikSolution
36.5 µl ddH2O
5 µl of 10x reaction buffer
2 µl (10 ng) of pBluescript-lz/
pCR Blunt ExonV
1.25 µl (125 ng) of SDMF
1.25 µl (125 ng) of SDMR
1 µl of dNTP mix (10 mM)
3 µl of QuikSolution
35.5 µl ddH2O
1 µl of PfuTurbo DNA polymerase was then added and following cycling
parameters were used:
Segment Cycles Temperature Time
1 1 95 °C 60 seconds
95 °C 50 seconds
68 °C 50 seconds
2 18
68 °C 1 minutes/Kb
3 1 68 °C 7 minutes
Table 2: Cycling parameters for Site directed Mutagenesis.
Following temperature cycling, the tubes were immediately placed on ice
for 2 minutes. Amplification of the product was checked by electrophoresis of 10
ml of the product on a 1% agarose gel.
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Dpn I Digestion of the Amplification Products
1 µl of Dpn I restriction enzyme (10 U/ml) was then added and mixed
gently and thoroughly by pipetting. The tubes were incubated at 37°C for 1 hour
to allow digestion of the parental supercoiled dsDNA.
Transformation of XL 10 Gold Ultracompetent Cells
Cells were thawed on ice and 45 ml was aliquoted in prechilled Falcon
2059 polypropylene tubes. 2 ml of b-ME was then added and the contents were
swirled gently. The tubes were incubated on ice for 10 minutes and swirled every
2 minutes. 2 ml of Dpn-I treated DNA was added to the cells and kept on ice for
30 minutes. Treatment with b-ME was followed by heat pulsing, which
permeablized the cells. Tubes were heat pulsed in a 42°C water bath for 40
seconds and transferred on ice for 2 minutes. 0.5 ml of preheated NYZ broth was
then added and the tubes were incubated at 37°C for 2-3 hrs with shaking at 250
rpm. 200 ml of the transformation reaction was plated on the LB-kanamycin for
lozenge and LB-Ampicillin for Exon V containing 80 mg/ml X-gal and 20 mM IPTG
and incubated at 37°C for 18 hours. Transformation efficiency was calculated for
all the transformations.
Recovery of the Mutant Constructs
5 ml of LB with appropriate antibiotic was inoculated with a single colony
and incubated overnight at 37°C with shaking at 250rpm. Colonies were
harvested and DNA was isolated using Wizard plus SV Miniprep DNA
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Purification System by Promega (Catalog #A1340). 1% agarose gels were run to
check the product size.
Sequencing
Quantification of DNA was done by spectrophotometer and 250 ng of each
mutant clone was sent for sequencing to the Molecular Medicine Institute,
Pittsburgh (http://www.mmi.pitt.edu/dnaseq.html). Exhaustive sequencing of both
the mutant clones was done to ensure that no mutation other than that desired
was incorporated in the clones.
Subcloning: Construction of Fusion gene
Lozenge, pointed P2, lozenge Exon V and the mutants were prepared for
cloning in the yeast plasmids by PCR with appropriate restriction sites
incorporated into the primers. Each of the above listed candidates was cloned in
both the yeast plasmids, i.e., yeast plasmid containing the GAL4 DNA binding
domain (pGBKT7) and plasmid containing the GAL4 activation domain
(pGADT7).
Primer Design and Amplification
Forward and reverse primers were designed to introduce compatible
restriction enzyme sites and 2 additional bases were added at the 5¢ ends to
allow for efficient digestion by restriction enzyme. In order to conserve the frame
of the fusion genes extra bases were added for cloning of pointed P2 in to the
yeast plasmid.
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Fusion gene Yeast
Plasmid
Primer sequence Temperature
Length
pGBKT7 GBTK7LzF=GCGAATTCATGCATTTGCATCTCCTGGCGGA
GBTK7LzR=GCCCCGGGTCAATAGGGTCGCCACACCT
Tm 69.9°C
Length 32
Tm 72.2°C
Length 28
Lozenge (Lz)
+
Lozenge Mutant
(LzSDM)
pGATD7 GADT7LzF=GCGAATTCATGCATTTGCATCTCCTGGCGGA
GADT7LzR=GCCCCGGGTCAATAGGGTCGCCACACCT
Tm 69.9°C
Length 32
Tm 72.2°C
Length 28
pGBKT7 GBKT7LzE5F=GCGGATCCGTCCGACCGGTGGTCC
GADT7LzE5R=GCCTGCAGTGCTTGTATGTGCGGCGC
Tm 70.5°C
Length 24
Tm 70.1°C
Length 26
Lozenge ExonV
(LzE5)
+
Lozenge ExonV
Mutant (LzE5SDM) pGADT7 GADT7LZE5F=GCCCCGGGTAGTCCGACCGGTGGTCCG
GADT7LZE5=GCGGATCCTGCTTGTATGTGCGGCGTT
Tm 74.4°C
Length 27
Tm 70.2°C
Length 29
pGBKT7 GBTK7PF=GCGGATCCGTATGGAATTGGCGATTTGTAA
GBTK7PR=GCCTGCAGCTAATCCACATCTTTTTTCTCAAC
Tm 64.6°C
Length 30
Tm 63.5°C
Length 33
Pointed P2
pGADT7 GADT7PF=GCCCCGGGTATGGAATTGGCGATTTGTAAA
GADT7PR=GCGGATCCCTAATCCACATCTTTTTTCTCA
Tm 66.5°C
Length 30ntd
Tm 62.6°C
Length 31ntd
Table 3: List of Primers designed for Subcloning
experiment.
Amplification
Gene fragments were generated by PCR utilizing the Stratagene PCR kit
(cat #200516). Thin walled 0.5 ml PCR tubes were used and each reaction was
set in volume of 50 ml as follows:
Reaction buffer                            5 ml
Quick Solution                             3 ml
Forward Primer                           1.25 ml (100 ng/ml)
Reverse Primer                           1.25 ml (100 ng/ml)
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d NTPs                                          1 ml
Plasmid                                           2-3 ml (200-300 ng)
ddH2O                                              up to 50 ml
Pfu Turbo DNA polymerase        1 ml (2.5U/ ml)
Denaturation was done at 95°C for 1 minute to start, then 50 seconds per
cycle. Annealing for 50 seconds at 60°C followed by extension for 1minute/kb of
the gene or gene fragment at 68°C. This was repeated for 18 cycles and finally
terminated with an extension step at 68°C for 7 minutes for all samples. All
products obtained were analyzed by gel electrophoresis.
Gel Clean up
PCR products were purified to remove unincorporated nucleotides.
Samples were run on 1% low melting agarose to allow isolation of proper
fragments. Correct size bands were excised with a clean fresh razor blade and
Wizard SV gel and PCR clean-up system (Promega cat #A98280) was used for
purification. About 95% product recovery was made and this was confirmed by
running 1% agarose gel at 80 volts for 2 hours. The amount of DNA was
estimated by spectrophotometer.
Restriction Enzyme Digestion
Digestion by Xma I and Eco R I
Lozenge in pBluescript/ pCR blunt, mutant Lozenge in pBluescript and
yeast plasmids pGBKT7 & pGADT7 were digested with the above two restriction
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enzymes. Buffer compatibility was taken into consideration in doing the double
digests hence digestion by Xma I (New England Biolabs cat #R0180S) was done
first. The digests were then cleaned by Wizard SV PCR clean up system.
Digestion with EcoR I (New England Biolabs cat #R0101S) was done next and
again the digests were purified. The reactions were assembled on ice in the
order listed below. Buffers and BSA were always kept 1/10th and 1/100th of the
reaction volume, respectively.
Xma I EcoR I
DNA(Plasmids,Gene
fragments) 1 mg
dH2O to make 50 ml
NEBuffer4 5 ml
BSA 0.5 ml.
45 ml of the purified Xma I
digest
dh2O to make 50 ml
NEBuffer EcoR I 5 ml
-
Gently mix by pipetting
Xma I 1 ml (10,000 U/ml) EcoR I 0.5 ml (20,000 U/ml)
Mix by pipetting
Kept in 37°C water bath for 90 minutes
Heat inactivated in 65°C water bath for 20 minutes
Table 4: Restriction Digests for Subcloning.
Digestion by Xma I and BamH I
Pointed P2, lozenge Exon V, mutant lozenge Exon V and yeast plasmid
pGADT7 were digested by these two enzymes, assembled and purified
according to the table presented above. 0.5 ml (10 U/ ml) of BamH I (Fisher cat
#BP3320-1) was used on purified Xma I digest and the reaction was incubated in
37°C for 2 hours.
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Digestion by Pst I and BamH I
Pointed P2, lozenge Exon V, mutant lozenge Exon V and yeast plasmid
pGBKT7 were first digested with Pst I followed by BamH I. 0.5 ml (10 U/ ml) of Pst
I (Fisher cat #BP3404-5) was used.
Dephosphorylation and Ligation
Calf Intestinal Alkaline Phosphatase (CIAP Promega cat #M1821) was
used to catalyze the hydrolysis of the 5¢ end and 3¢ end phosphate from the
plasmid to prevent vector religation, which reduces the number of background
colonies. Just prior to use CIAP was diluted in CIAP 1X reaction buffer to a final
concentration of 0.01 U/ml. Amount of CIAP was calculated according to the pmol
of DNA ends. For dephosphorylation, the vector digest, 5 ml CIAP buffer and 0.5
m l calf intestinal phosphatase was added to an end volume of 50 m l and
incubated in 37° C water bath for 30 minutes. An additional batch of enzyme (0.5
ml) was added and incubated for further 30 minutes. 300 ml of CIAP stop buffer
was added to terminate the reaction. The dephosphorylation was followed by
purification step to remove any phosphatase left in the solution.
Molar ratio of 3:1 of insert: vector was used for ligation. Conversion of
molar ratios to mass ratios was done using the formulae:
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The reaction was assembled in sterile microcentrifuge tube as shown:
Vector DNA 2 ml (40 ng)
Insert DNA 6 ml (120 ng)
Ligase10x Buffer 1 ml
T4 DNA ligase 0.5 ml
ddH2O 2.5 ml
The tubes were incubated at 4°C overnight.
Transformation and Miniprep
E.coli JM109 cells were used for transformation. 3 ml of the ligase reaction
mix was used and blue/white screening was done for selecting transformed
colonies. A single colony was used to inoculate 5 ml of LB broth containing
appropriate antibiotic. Following overnight culture, DNA was isolated using the
Wizard plus SV minipreps DNA purification system (Promega cat #A1330).
Sequencing
DNA was quantified by spectrophotometer. All clones were thoroughly
screened by designing appropriate primers. Each sequencing reaction gave 800-
900bp of readable sequences. Sequencing was done at the Molecular Medicine
Institute, Pittsburgh (http://www.mmi.pitt.edu/dnaseq.html). Frame and point
mutations were exhaustively searched for.
35
Figure 7: Location of Primers designed for sequencing.
Primers for lozenge Primers for pointed P2
BT7
ADT7
T7
LZ F3
Lz F4
LZ F6
LZ F7
AD
BD
RBT7
LZ R3
LZ R4
LZ R6
LZ R7
TCATCGGAAGAGAGTAGTAACAAA
CTATTCGATGATGAAGATACCCCA
TAATACGACTCACTATAGGGC
AGCAATAGCAACAATAACAAC
AGTTCAATGATCTGCGTTTC
GAATAGTACAATCAACTCGGACT
GACAAATGGATCCTCGAGTT
AGATGGTGCACGATGCACAG
TTTTCGTTTTAAAACCTAAGAGTC
TTTGTTACTACTCTCTTCCGATGA
GTTGTTATTGTTGCTATTGCT
GAAACGCAGATCATTGAACT
CGAGTTGATTGTACTATTCG
AACTCGAGGATCCATTTGTC
BT7
ADT7
T7
PF1
PF2
PF3
PF4
AD
BD
PR1
PR2
PR3
TCATCGGAAGAGAGTAGTAACAAA
CTATTCGATGATGAAGATACCCCA
TAATACGACTCACTATAGGGC
ACCGAGGTACTGAAGGCATCC
ACAGCAAAGCAACGAACGAAAATACAC
GATGCTCAATCCTTCCAGTCG
TACTATTATGACAAAAAACA
AGATGGTGCACGATGCACAG
TTTTCGTTTTAAAACCTAAGAGTC
GGATGCCTTCAGTACCTCGGT
GTGTATTTTCGTTCGTTCTTTGCTGT
CGACTGGAAGGATTGAGCATC
Table 5: Primers designed for Sequencing
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Yeast Two–Hybrid System
Matchmaker Gal4 Two-Hybrid by Clontech (cat #K1261-1) was used. It is
an advanced Gal4-based two-hybrid system that provides a transcriptional assay
for detecting protein interaction in vivo in yeast. In addition, the Matchmaker
System 3 DNA-BD and AD fusion vectors, pGBKT7 and pGADT7 have been
designed for high level protein expression. The “bait” and “prey” inserts are
expressed as GAL4 fusion with c-myc and HA epitope tags respectively which
eliminates the need for generating specific antibodies allowing convenient
identification of the fusion proteins.
Figure 8: Yeast two hybrid system
A B
   
(A) Protein X (the bait protein is fused to DNA-binding domain (DBD) and
protein Y is fused to transcription activation domain (AD). Both hybrid proteins
are expressed in yeast cells from plasmid. Interaction of X and Y leads to
activation of reporter gene that allow the yeast to grow on a defined medium. (B)
Protein X and Y do not interact; consequently, the reporter gene is not
expressed.
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Yeast Strains
Two yeast strains were provided with the kit. Y187, which uses a lacZ
reporter encoding b-galactosidase, and AH109, which in addition to lacZ has two
other reporter genes HIS3 and ADE2. These two genes provide strong nutritional
selection for positive clones. Both of the strains were recovered from frozen
stocks by streaking on YPDA plates. Both the strains exhibit an ade2-101
phenotype and turn pink when grown on the YPDA plates at 30°C for 3-5 days or
until the colonies are about 2-3mm in diameter. Several such colonies were used
to inoculate 5 ml YPDA liquid media to prepare liquid cultures for transformation.
The tubes were vortexed vigorously to disperse any clumps and were incubated
at 30°C for 16-18 hrs with shaking at 230-270rpm.
Checking Reporter Activity for Individual Plasmid Constructs
The overnight cultures were grown to stationary phase (OD600>1.5). This
culture was used to inoculate another 50 ml culture to produce an OD600 of 0.2-
0.3. The flask was incubated at 30°C for 5 hours with shaking (230-270 rpm) to
get a mid-log phase measuring an OD600 of 0.5± 0.1. This culture is sufficient for
10 transformations. The culture was harvested in sterile 50 ml centrifuge tube at
3000xg (2500 rpm) for 5 minutes. The medium was poured off and 25 ml of
sterile dH2O was added to resuspend the cells. The tubes were centrifuged again
to remove the water. 1.0 ml of 100 mM lithium acetate (LiAc) was added to the
pellet and vortexed to resuspend the cells. This allows permeabilization of the
yeast cells. The suspension was transferred to sterile microcentrifuge tubes and
cells were centrifuged at top speed for 5 seconds. LiAc was removed carefully
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with a pipette. 400 ml of 100 mM LiAc was then added and pellet vortexed to get
a final volume of 500 ml. 50 ml of this was transferred to new microcentrifuge tube
for each transformation. The cells were centrifuged again to remove LiAc. The
transformation mix was then added to tubes in the order shown below:
• 240 ml of PEG (50% w/v)
• 36 ml of 1.0 M LiAc
• 25 ml of single stranded carrier DNA (2.0 mg/ml)
• 50 ml of H2O and plasmid DNA (1 mg)
Each tube was vortexed until the pellet completely dissolved. The tubes
were incubated at 30°C for 45 minutes followed by heat shock at 42°C for 25
minutes. Cells were centrifuged at 6000 rpm for 20 seconds to remove the
transformation mix. 500 ml of sterile dH2O was added to the tubes and the pellet
was resuspended by pipetting gently. 200 ml of it was used for plating onto
appropriate selective plates.
Detection of Reporter Activity: Colony–lift Filter Assay
Colony–lift filter assay was used to detect reporter lacZ gene activity. It
measured the b-galactosidase activity encoded by lacZ. It was used to screen
the large number of transformants that survived the nutritional selection.
Plates were incubated at 30°C until colonies appear and grew to size of 1-
2 mm, this usually took 4-5 days. For each plate of transformants assayed, a
sterile Whatman #5 or VWR grade 410 filter was used. It was placed in 2.5-5.0
ml of Z buffer/X-gal solution in a clean 150 mm plate. Using clean forceps, a
clean dry filter was placed over the surface of the plate of colonies and gently
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rubbed with the side of the forceps, which helped the colonies to cling to the filter.
After the filter was evenly wetted, it was carefully lifted off the agar plate and
transferred to a pool of liquid nitrogen (colonies facing up). Liquid nitrogen lyses
the yeast cell thus allowing detection of the reporter gene. The filters were
submerged for 10 seconds after which they were completely thawed at room
temperature. The filter colony side facing up was then cautiously placed on the
presoaked filter careful not to trap any bubbles between the two filters. Filters
were incubated at 30°C and checked periodically for the appearance of
blue/white color. White colored colonies were indicative that all clones by
themselves were not activating the reporter lacZ gene activity.
Co- transformation of Yeast strains for Protein-Protein Interaction
Yeast colonies were grown in 5 ml YPDA media overnight at 30°C
(shaking at 250 rpm) and were used to inoculate 50 ml of YPDA media. The
colonies were grown until mid log phase and then prepared by transformation as
described earlier. In the DNA mix a 2:1 molar ratio of bait to prey DNA was used
for co-transformation. The transformation mix was plated on an SD minimal
media -Leu/-Trp. The plated were incubated at 30°C and as soon as the colonies
appeared were tested for b-galactosidase activity. Colony filter lift assay were
performed as already discussed. Positive clones were identified as blue colonies
and restreaked on fresh plates to confirm interaction.
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Verification of Protein Expression: Western blotting
Preparation of Protein Extract
For each transformed yeast strain assayed, a 5 ml SD minimal media
–Leu/-Trp culture was started and incubated for 7-8 hours at 30°C. It was used to
start a 25 ml culture at an OD600 of 0.05 and incubated overnight at 30°C with
shaking. The cultures were centrifuged at 3000 rpm for 5 minutes and the
supernatant discarded. The pellet was resuspended by vortexing in 0.5 ml of
sterile dH2O and transferred to sterile microcentrifuge tube. Tubes were
centrifuged at 9000 rpm for 1 minute to remove water and then resuspended in
200 ml ice-cold extraction buffer and lysed with glass beads with 8 cycles of 30
seconds vortexing with 30 seconds pausing on ice. Unbroken cells and debris
were removed by centrifugation at 10,000 rpm for 10 seconds. The supernatant
was removed and kept on ice henceforth.
Western Analysis
 Protein concentrations were determined using Bicinchoninic Acid Protein
Assay Kit from Sigma (cat #BCA-1). Samples were heated at 37°C for 10 min
with Tris–Gly SDS sample buffer 2X (Novex LC2676). A total of 40-50 mg was
loaded per lane into 4-20% Tris-Gly Gels 1.5 mmx10 well (Invitrogen EC6028)
and Benchmark Prestained Protein Ladder (Invitrogen LC2005) and MagicMark
Western Standard (Invitrogen LC5600) were used as standards. Gels were
sandwiched with PVDF transfer memberane (Invitrolon PVDF, Invitrogen
LC2005) and samples were transferred on membrane using the Xcell II blot
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Module from Invitrogen (E19051) at 20V for 2 hours. Membranes were stained
using Ponceau 0.5 % in 1% acetic acid for 5 minutes and then thoroughly rinsed
in deionzed water to check the efficiency of the transfer. The membrane was
dried and scanned for records. Membrane was treated for 5 minutes in HPLC
grade methanol rinsed with deionzed water and transferred in 1% BSA in PBS-
Tween for blocking. It was kept in blocking solution overnight at 4°C in with
shaking. Equilibration of membrane was done for 15 minutes at room
temperature. Primary antibody (Monoclonal Antibody HA-11, Covance cat#
MMS-101P and Monoclonal antibody c-Myc, Clontech cat #3800-1) was added to
solution at 1:5000 dilution ratio and incubated at room temperature with shaking
for 90 minutes. Primary antibody solutions were removed and the membrane was
washed with PBS-T for 30 minutes changing the solution every 5-6 minutes.
Membrane was incubated in secondary antibody (Peroxidase-labeled affinity
purified antibody to mouse IgG (H+L), KPL cat# 074-1806) in 1% BSA/PBS-T at
1:75000 dilution for 1 hour at room temperature. Membrane was washed for 30
minutes in PBS-T, with changing the solution every 5-6 minutes. It was incubated
with SuperSignal Dura Extended Duration Substrate (PIERCE cat #34057) for 5
minutes at room temperature and sealed using thin plastic. Membrane was
exposed to Kodak Biomax MR film for 5-10 minutes and developed.
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Preparation of Media and Reagents
Site Directed Mutagenesis and Subcloning
LB Agar (per liter)
10 g NaCl
10 g Tryptone
  5 g Yeast extract
20 g Agar
Added deionzed water to a final volume of 1 liter
Adjusted pH to7.0 with 5 N NaOH
Autoclaved
Cooled to 55°C
Added 50 mg of filter-sterilized ampicillin/kanamycin
Poured into Petri dishes
NYZ+ Broth (per liter)
10 g NZ amine
  5 g Yeast extract
  5 g NaCl
Added deionzed water to a final volume of 1 liter
Adjusted pH to 7.5
Autoclaved
Added the following filter-sterilized supplements prior to use
12.5 ml of 1M MgCl2
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12.5 ml of 1M MgSo4
20 ml of 20% (w/v) glucose
SOB Medium (per liter)
20.0 g Tryptone
5.0 g of NaCl
Autoclaved
Added 10 ml of 1 M MgCl2 and 10ml of 1 M MgSo4/liter of SOB medium
prior to use.
SOC Medium (per liter)
SOB medium
Added 1 ml of a 2 M filter-sterilized glucose solution and filter sterilized.
CIAP Stop Buffer
10 mM Tris-HCL (pH 7.5)
 1 mM EDTA
 200 mM NaCl
  0.5% SDS
Yeast Two Hybrid
YPDA (per liter)
960 ml d H20
50 g YPD
44
15 ml of 0.2% adenine hemisulfate
20 g agar added for plates
Deionzed water to make 1L
Adjust pH to 6.5
Autoclaved for 30 minutes
Pour plates
SD Medium (per liter)
 6.7 g Yeast nitrogen base without amino acids
 20 g Agar (only for plates)
  5 g Ammonium sulfate
20 g dextrose
100 ml (6.4 g/100 ml) of 10X Dropout solution (all amino acids expect
–Leu/-Trp)
Deionzed water to make 1000 ml
Autoclaved for 30 minutes
Poured plates
For single transformation the amino acid not carried by plasmid was also
added to media. (200 mg/L for Trp and 1000 mg/L for Leu)
b-galactosidase Filter Assay
Z Buffer
Na2HPO4.7H2O 16.1 g/L
NaH2PO4.H2O 5.50 g/L
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KCL 0.75 g/L
MgSO4.7H2O 0.246 g/L
Adjusted the pH to 7.0 and autoclaved
X-gal Solution
20 mg /ml in DMF
Z Buffer/ X-gal solution
100 ml Z-buffer
0.27 ml b-mercaptoethanol
1.67 ml X-gal stock solution
Western Analysis
Extraction Buffer (200 ml)
1760 ml Buffer “Western”
  200 ml Triton X-100
    20 ml 100 mM PMSF
    20 ml 10% SDS
Primary Antibody (1:5000)
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150 ml PBST
1.5 g BSA
30 ml primary antibody
Secondary Antibody (1:75000)
150 ml PBS-T
1.5 g BSA
 2 ml secondary antibody
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RESULTS
Overview
The vertebrate transcription factors Ets-1 and AML-1 (the Runx family aB1
subunit of murine PEBP2a ) play critical roles in hematopoiesis and
leukemogenesis, and cooperate in the transactivation of the T-cell receptor b
chain enhancer. Kim and coworkers (1999) reported a direct interaction between
Ets-1 and PEBP2a. They also showed that this interaction leads to a reciprocal
stimulation of their DNA binding activity and activation of their transactivation
activity.
Pointed (Ets-1) and Lozenge (Runx1) represent Drosophila homologs of
the two families of transcription factors. Interestingly, both genes are involved in
eye development, and binding sites for both have been found in close proximity
in the enhancers of several genes, including prospero (Flores et al, 2000).
Similar to the AML-1 factor our laboratory has previously shown that Lz is
alternatively spliced (Behan, 2001; Siddall et al., 2003). We have predicted
distinct roles for the two isoforms, the full-length lozenge (lz c3.5) and lozenge
lacking the exon V (lzD5) in eye development. Drawing from the similarities
between the vertebrate and Drosophila proteins, it is proposed that the RUNX-
Ets paradigm previously characterized (Kim et al., 1999) is recapitulated in
Drosophila eye development. We suggest that Lz-Pnt P2 cooperate to upregulate
Prospero expression for specifying R7 cell during development. Genetic
evidence for this observation has been presented by John Pollock’s prior
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graduate student Kristina Behan. However, evidence for a physical interaction
between the Lz and Pnt P2 proteins was lacking.
Experiments were thus designed and performed in the course of this
current study to search for a biochemical interaction between the Lz and Pnt P2
proteins that corroborate our findings. These involved site directed mutagenesis
of Lz in the alternatively spliced exon. Next, yeast two-hybrid analysis was
carried out to directly assess the biological interaction of the Lz proteins and Ets-
1 protein Pointed P2. This included the construction of yeast vector containing
Gal4 DNA binding domain fused to lozenge and the second yeast vector carrying
the activation domain fused to pointed P2. Western analysis of yeast cells
containing the two vectors confirmed the expression of the corresponding fusion
proteins. Lastly, extensive analysis of Lz (Runx-1) and Pnt P2P2 (Ets-1) protein
families was performed using a range proteomics databases and tools.
Lozenge and Pointed represent RUNX1 and Ets-1 by sequence and
functional homology
Lozenge and Pointed sequences were analyzed to investigate secondary
structure and protein domains. A figure illustrating the results derived for
Lozenge protein in comparison to mouse homolog is shown (Figure 10).
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Site Directed Mutagenesis: Modulating the putative Ets interacting domain
in Lz
On the basis of protein analysis by various automated databases and
sequence analysis, it was deduced that Exon V of lozenge encodes a putative
Ets interaction domain. Site directed mutagenesis was used to create a mutant
clone in which two contiguous amino acids, in the core of a highly conserved
domain in Exon V were altered. Using the PCR technique, primers containing the
desired sequence change, introduced the mutation. This was performed on both
full-length Lz sequence and a gene fragment encoding just exon V. The mutation
switched the charge of two amino acid residues from positively charged arginines
to negatively charged glutamic acid. The substitution was checked for secondary
structure and was found to keep the alpha helix intact. A 1% agarose gel was run
to check amplification and revealed the correct size band for both templates
including the control provided with the mutagenesis kit (Figure 11). Digestion of
the PCR product with Dpn I endonulease assured the removal of methylated
parental DNA template. This results in minimizing the background and selection
of mutation containing synthesized DNA. The next step involved the
transformation of competent cells and identification positive clones by blue/white
screening of LacZ induction. To demonstrate the effectiveness of the method, the
pWhitescript 4.5 kb containing a stop codon (TAA) at a position where glutamine
normally appears in the b-galactosidase gene was used as a control. The
oligonucleotide control primers created a point mutation that reversed the
change. Using 250 ml of the transformation reaction for each of the conditions
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including the pBluescript-lozenge and pCR Blunt–Exon V and pWhitsecript 4.5 kb
control plasmid were plated on LB-antibiotic plate containing X-gal and IPTG. As
control, pUC 18 plasmid was used to verify transformation efficiency. Following
transformation, colonies containing the mutated control plasmid appeared blue,
as did the colonies transformed with mutated plasmids. Mutagenesis efficiency
for each for calculated and is represented in the table given below:
Plasmid No. of
blue
colonies
No. of
white
colonies
Mutagenesis efficiency (ME)
= No.of blue colony forming units x100
  No.of total colony forming units
62 20 75.0%pBluescript-
lozenge
86 18 82.6%
58 12 82.8%pCRBlunt-
Exon V
74 23 76.2%
128 21 85.9%p Whitescript
4 . 5  k b
control 180 10 94.7%
Table 6: Mutagenesis efficiencies for experimental and
control transformations
Plasmid was recovered from isolated colonies grown in 5ml of LB-
antibiotic media. (Figure 11). Incorporation of mutant alters the recognization site
of restriction enzyme RsrII. The position 1549 CGGCGGTCCGCC represents
that site. Results confirm that the recovered plasmids contain the insert.
Gel purified plasmids were sequenced. Primers were designed such that
overlapping sequences were obtained. Each sequencing reaction yielded reading
lengths of about 800 bases. DNA StriderTM1.3f13 program was used to align and
examine the sequences obtained from lozenge mutant clone and from Exon V
clone. No ambiguities in terms of any insertions/deletions or base pair changes
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except the ones introduced by primes provided evidence for the success of
experiments. Sequencing was done for the opposite strand also and results
obtained corroborated the presence of mutated sequence. Mutant clones were
named Lz-SDM for full-length lozenge mutant and E5-SDM for Exon V mutant.
Interaction between the two proteins: Yeast Two Hybrid Assay
The yeast two-hybrid technique identifies the interaction between two proteins (X
and Y) by reconstituting a transcription factor that activates a reporter gene
driven by promoter containing the relevant binding site for transcription factor.
The system used for my experiments is Gal4 based. Two shuttle vectors
pGADT7 and pGBKT7 carry the activation domain and DNA binding domain of
Gal4 respectively. Genes of interests, pnt P2, lz, and mutant constructs were
fused to these domains. The reporter gene used in these experiments was the
bacterial lacZ. Also, growth selection markers such as LEU and HIS on the two
plasmids allowed powerful growth selections for successful transformants.
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Figure 9: Vectors used in the two-hybrid system and the
fusion proteins, which they encode.
Construction of fusion genes: pGADT7-lz and pGBKT7-pointed
In order to ensure success with yeast two-hybrid system the most critical
step involved the precise cloning of gene and gene fragments into appropriate
vectors. Careful design of primers ascertained appropriate reading-frame and
orientation for expression of the fusion proteins. Lozenge, lozenge Exon V,
pointed P2 and mutant clones were PCR amplified to introduce compatible
restriction sites. Amplification was checked by agarose gel electrophoresis and
the product was gel purified (Figure 12). Sequential restriction enzyme digests
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were done and the digested products were purified to remove traces of restriction
enzymes and buffers. Repeated purification ensured minimal interference with
optimal enzyme activity. Vectors were treated with a phosphatase enzyme and
purified. Dephosphorylation prevented the religation of vector during cloning and
also reduced number of background colonies. 1:3 ration of vector and insert was
used in ligation reaction. Ligation mix was used to transform E. coli competent
cells. More than 80% efficiency was achieved for all transformation. After the
plasmid isolation, products were checked electrophoretically and quantified
spectrophotometerically (Figure 12). Sequencing data established that cloned
inserts were in frame for translation with no base changes for all clones
constructed.
Table 7: Clones designed for Yeast Two-Hybrid.
Checking for auto activation
Since the two-hybrid system is based on the reconstitution of a functional
transcription factor, checking the auto-activation capacity of the target is crucial
for the overall feasibility. Y187 and AH109 strains were grown from frozen stocks
for 4-5 days at 30°C. Healthy colonies of 2-3 mm size appeared and were pink in
color and these were used to inoculate 5 ml of YPDA media. The cultures were
pGADT7-Activation Domain+ LEU2 pGBKT7-DNA binding domain+TRP
Lozenge (Lz)
Lozenge mutant (Lz SDM)
Pointed P2
Lozenge Exon V (E5)
Lozenge Exon V mutant (E5 SDM)
Lozenge (Lz)
Lozenge mutant (Lz SDM)
Pointed P2
Lozenge Exon V (E5)
Lozenge Exon V mutant (E5 SDM)
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allowed to grow until they reached the stationary phase and then transferred to
fresh 50 ml of YPDA media. Lithium Acetate (LiAc) transformation method was
used to transform the plasmids into yeast strains (auxotrophic for Trp and Leu).
For all yeast strain that were transformed with pGADT7, SD-Leu media
supplemented with Trp was used and vice versa for all strains transformed with
pGBKT7. The cells were plated in triplicate for each transformation. Colonies
appeared from all transformation reactions within of 4-5 days. Six colonies from
each plate were spread into patches on a fresh plate and incubated until colonies
appeared. b-galactosidase colony lift filter assay was done to detect lacZ activity.
LacZ is the reporter gene under the control of GAL4-responsive sequences.
Filters were checked periodically for color development. The pCL1 plasmid that
encodes the full-length wild type GAL4 protein was used as a positive control for
b-galactosidase assay. None of the single transformants were blue. The above
experiment verified that the constructs by themselves were unable to activate the
reporter genes. A schematic showing the procedure and the result obtained for
one such experiment is shown in figure 13.
Simultaneous vs. sequential transformation
In my next set of experiments I picked all single transformants colonies
and prepared them for a sequential transformation. A table depicting all possible
combination used for experiments is shown. Both positive and negative controls
comprising plasmids pGADT7-T + pGBKT7-53 and pGADT7-T +pGBKT7-Lam
were included in the experiments. 200 ml of each was plated on SD/-Leu/-Trp. It
took the more than 5 days for the colonies to appear, indicating that colonies
55
grew far slower with both the plasmids This was also done in triplicate and 6
colonies from each plate were patched on a fresh plate to be assayed for
reporter gene activity. Single colonies from the positive control plates were also
included to make one patch on all plates. After incubating the filters for 8 hours at
30°C the experimental colonies showed no lacZ activity and were white colored.
The positive and negative controls yielded expected blue and white colonies
respectively, on the filters. The assay was repeated to screen all colonies and the
same result was obtained.
Single transformant Plasmid for sequential transformation
Lozenge (Lz)
Lozenge mutant (Lz SDM)
Lozenge Exon V (E5)
Lozenge Exon V mutant
(E5 SDM)
Pointed P2
pGADT7
Pointed P2
pGBKT7
Lozenge (Lz)
Lozenge mutant (Lz SDM)
Lozenge Exon V (E5)
Lozenge Exon V mutant (E5
SDM)
Lozenge (Lz)
Lozenge mutant (Lz SDM)
Lozenge Exon V (E5)
Lozenge Exon V mutant
(E5 SDM)
Pointed P2
pGBKT7 Pointed P2 pGADT7
Lozenge (Lz)
Lozenge mutant (Lz SDM)
Lozenge Exon V (E5)
Lozenge Exon V mutant (E5
SDM)
Table 8: Combinations used for Sequential transformation.
Appearance of blue color for positive and white for negative controls
indicated that transformation protocol worked even though all experimental
colonies gave no reporter gene activity. Protein was extracted from experimental
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colonies that failed to show positive interactions and a Western analysis was
done. Figure 14 illustrating the number of times each experiment was tried and
tested in shown at the end of the chapter.
Results of Simultaneous co–transformation
Given the failure to detect reporter gene activity in sequential
transformants, a different transformation approach that involved a little tweaking
form the earlier approach was used. Both yeast strains AH109 and Y187 were
grown to stationary phase and transferred to a 50ml fresh YPDA media for a
small-scale transformation. Bait to prey ratio of 2:1 was used and the incubation
time with the transformation mix was increased by 15 minutes from the previous
transformation. Colonies appeared after incubating for 2-3 days and were
immediately screened for reporter gene activity. Incubation of 2 hours gave color
development on the filters (Figure 16). All experimental colonies transformed with
Lz and Pnt P2 fusion proteins except the mutated Exon V construct gave blue
color for lacZ activity. Positive and negative controls were as expected. The
positive colonies for all experimental candidates were re-streaked on fresh plates
in patches and assayed for reporter gene activity. Appearance of blue color
confirmed the fact that there was an interaction between the proteins. The
experiments were repeated thrice to ascertain the interaction (Figure 15). Table 9
shows the percentage colonies that showed reporter gene activity in co-
transformation experiements.
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Detection of Fusion proteins
In addition to the fusion with the Gal4 domains, the two interacting
proteins are also expressed as a fusion to a c-myc and hemagglutinin tags. The
epitope tags allow easy detection of the proteins thus eliminating the need to
generate specific antibodies.
Hence, to verify the presence of proteins in the double transformants, protein
was extracted and a Western blot was done. Controls for the experiments
included protein extracted from untransformed yeast strains and positive controls
from co-transformed colonies. Protein extract from a sequentially transformed
colony was also included (Figure 17). Lozenge and Exon V, pointed P2 proteins
were detected from colonies transformed with pGBKT7-PNT P2 and pGADT7-Lz/
LzSDM/E5/E5SDM. Untransformed yeast strains showed no bands. Interestingly,
only one of the proteins was detected in sequential transformants explaining the
failure to detect reporter gene activity. Also in my first Co-transformation
experiment I did not detect reporter gene activity for  p GBKT7-Pnt P2  and p
GADT7-E5 as I did in my second experiment, which is explained by absence of
partner PNT P2 protein evident in western blot.
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Figure 10: Schematic representation of the secondary
structure of Lz protein.
ClustalW alignment of Lz with murine Runx1 protein isoform, PEBP2aB1
(represented as PEBP2a) is shown. The secondary structure determined for Lz
protein is represented above the sequences. Alpha helices are shown in pink,
beta strands are depicted in yellow arrows, Red and green curved arrows
indicate the Beta hairpin and Beta turn respectively. Blue lines indicate random
coils. Purple arrows show exon boundaries for Lz protein. Orange square on
PEBP2aB1 sequence marks the exon that is alternatively spliced
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Figure 11: Site directed mutagenesis.
Panel A: Site directed mutagenesis was performed on full-length lozenge.
Lane 1 and 2: plasmids p Bluescript-lz (6.2 kb) pCR Blunt-lz (6.2 kb) respectively.
Lane 3 to 5: PCR product of plasmids p Bluescript-lz, pCR Blunt-lz and pUC18
control plasmid (5 kb). Lane 6 and 7:Mutated lz in p Bluecscript and pCR Blunt
isolated from competent cells. Panel B: Site directed mutagenesis of lozenge
exon V (E5) in pCR Blunt. Lane 1 and 2: template plasmids pCR Blunt-E5 (4 kb).
Lane 3 and 4: Product obtained after Mutant strand synthesis by PCR. Lane
5:Isolation of mutated pCR Blunt E5 from competent cells.
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Figure 12: Subcloning of gene of interest in Yeast plasmids.
Panel A: Compatible restriction sites were introduced by PCR and the product
checked on 1%Agaraose gel. Lane 1: pointed p2, Lane 2 and 3: PCR product
from p Bluescript-lz and p Bluescript-lz SDM, Lane 4 and 5: PCR product from
pCR Blunt-lz and pCR Blunt-lz-SDM, Lane 6 and 7: PCR product from pCR
Blunt–lz E5, Lane 8 and 9: PCR product from pCR Blunt–lz E5 SDM. Panel B:
Plasmids isolated from competent cells transformed with ligation mixture of the
gene of interest and yeast plasmid. p GBKT7 (7.3 kb) containing Gal4 DNA
binding domain. Lane 1: Pointed p2 in p GBKT7, Lane 2 and 3: Lozenge and
lozenge SDM in p GBKT7, Lane 4 and 5: Lozenge E5 in p GBKT7, Lane 6 and 7:
Lozenge E5 SDM in p GBKT7. Panel C: p GADT7 (8.0 kb) containing Gal4
activation domain and gene of interest. Lane 1 and 2: Pointed p2 in p GADT7,
Lane 3 and 4: Lozenge in p GADT7, Lane 5 and 6: Lozenge SDM in p GADT7,
Lane 7: Lozenge E5 in p GADT7, Lane 8: Lozenge E5 SDM in p GADT7
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Figure 13: Checking for autoactivation.
Yeasts were transformed with all plasmids constructed to check for auto-
activation and assayed for LacZ activity. All experimental colonies show no LacZ
activity. Positive control in the experiment was colonies that were transformed
with pCL1 plasmid encoding full length Gal4 transcription factor.
Colony lift filter Assay
SD-LEU
SD-TRP
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Figure 14: Schematic showing the result obtained for all
combinations utilizing Sequential transformation
experiments.
Plate A
Plate B
Plate C
Plate 1A
Plate 2A
Plate 3A
Plate 1ABC
Plate 2ABC
Plate 3ABC
5-6 Days
Filter
Assay
Filter
Assay
Filter
Assay
Plate A
Plate B
Plate C
Checking Autoactivation
Filter
Assay
5-6 Days
Filter
Assay
1-2 Days1-2 Days2-3 Days
Sequential Transformation
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Figure 15: Schematic showing the plating and re-streaking
done for Lz + Pnt P2, Lz SDM + Pnt P2, Lz E5 + Pnt P2
combinations utilizing Co-transformation experiments
Co-transformation
mix
Lz +Pnt P2
Lz SDM + Pnt P2
Lz E5 + Pnt P2
Plate A
Plate B
Plate C
Plate 1A
Plate 2A
Plate 3A
Plate 1ABC
Plate 2ABC
Plate 3ABC
Plating done in triplicates from
each transformation mix
9 Colonies selected from
each plate and restreaked
in patches
6 colonies were
used to streak
fresh pates
3-4 Days 1-2 Days 1-2 Days
Western
Analysis
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Figure 16: Detection of reporter gene activity in Co-
transformed yeast colonies.
Interaction of full-length Lz, Lz E5, Lz SDM, Lz E5 SDM with Pnt P2 protein.
Plates were streaked with single colony of yeast transformants that contain
plasmids expressing different GAL4 DNA binding Domain and GAL4 activation
domain fusion proteins are shown. Cell growth on Leu-/Trp- medium
demonstrates successful transformation. The colonies were lifted on a filter and
assayed for LacZ activity. Positive interaction between proteins is indicated by
development of blue color on the filters incubated with the X-gal substrate. The
schematic in the bottom indicates the Gal4 fusion proteins expressed in
transformants streaked in each sector of the plate.
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Table 9: Percentage colonies that showed Reporter gene activity after Co-transformation.
Results shown for co-transformation experiments only. All experiments done using
sequential transformation gave no reporter gene activity. Positive and negative controls in
the sequential transformation gave same results as shown here for co-transformation.*
Because colony distribution was not uniform an area of high colony density was used for
counting. ± Signifies the combinations that were used in western blots.
Yeast plasmids
Whole plates
>200 Colonies
Patch plates
9 colonies
selected from
each whole
plate
Streaked plates
pGADT7
Activation
Domain
 pGBKT7
DNA
Binding
Domain 1A 2A
* 3A* 1AB 2AB 3AB 1ABC 2ABC 3ABC
Lz 42%
88/210
56%
6/11
49%
5/12
100% 100% 100% 100% 100% 100%
Lz SDM 54%
122/225
35%
3/8
41%
4/9
100% 100% 100% 100% 100% 100%
Exon V 53%
111/208
72%
9/13
68%
10/15
100% 100% 100% 100% 100% 100%
Pnt P2
Exon V
SDM
0%
0/209
0%
0/13
0%
0/12
0% 0% 0% 0% 0% 0%
Lz± 45%
98/223
50
5/10%
67%
6/9
100% 100% 100% 100% 100% 100%
Lz SDM± 63%
151/241
61%
8/13
50%
6/12
100% 100% 100% 100% 100% 100%
Exon V± 65%
149/232
63%
7/11
76%
6/8
100% 100% 100% 100% 100% 100%
Exon V
SDM±
Pnt P2±
0%
0/214
0%
0/12
0%
0/14
0% 0% 0% 0% 0% 0%
Positive control
pGADT7-T + pGBKT7-
53
100% 100% 100% 100% 100% 100% 100% 100% 100%
Negative control
pGADT7-T + pGBKT7-
Lam
0% 0% 0% 0% 0% 0% 0% 0% 0%
b Galactosidase
control
pCL1
100% 100% 100% 100% 100% 100% 100% 100% 100%
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Figure 17: Western analysis of epitope-tagged fusion
proteins.
Soluble protein extracts were prepared from yeast strain AH109 and Y187, co-
transformed with p GBKT7 encoding c-Myc tagged Gal4 DNA binding domain
(DBD) fusion protein and p GADT7 encoding HA tagged Gal4 Activation domain
(AD) fusion protein. Each well contains 50 mg of protein. Gels were run in
duplicate and probed with different antibodies. Panel A and D: Samples probed
with anti-c-Myc antibody and anti-HA antibody respectively. (Pnt P2~81kD; Gal4
DBD~25kD) (Lz/LzSDM~90kD; Gal4 AD~30kD) Lane 1: AH019 (p GBKT7-Pnt
P2 and p GADT7-Lz), Lane 2: AH109 (p GBKT7-Pnt P2 and p GADT7-Lz SDM),
Lane 3: Y187 (p GBKT7-Pnt P2 and p GADT7-Lz), Lane 4: Y187 (p GBKT7-Pnt
P2 and p GADT7-Lz SDM). Panel B and D: Samples probed with anti-c-Myc
antibody and anti-HA antibody respectively. (LzE5 ~7 Kd+ Activation Domain
~30kD), Lane 1: AH019 (p GBKT7-Pnt P2 and p GADT7-Lz E5), Lane 2: AH109
(p GBKT7-Pnt P2 and p GADT7-Lz E5 SDM). Panel C and F: Samples probed
with anti-c-Myc antibody and anti-HA antibody respectively. Lane 1 and 2
represent sequential transformed experiment, no Lz is detected which explains
the failure to detect reporter gene activity. Lane 3 represents the E5+PNT P2
combination that did not show reporter gene activity in first set of co-
transformation experiment. Untransformed yeast strains were run as control and
showed no specific bands.
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DISCUSSION
Results presented in this study illustrate, for the first time that lozenge and
pointed, homologs of Runt1 and Ets-1 family, interact at the protein level. In
Drosophila, Lz and Pnt P2 cooperation is central to the specification of the R7
cell fate and establishing the structure of the eye (Behan et al., 2002; Xu et al.,
2000). Evidence for their physical interaction is provided by employing the yeast
two-hybrid system. Further, the data obtained, unequivocally demonstrate that
the concert between the Lz and Pnt P2 occurs independent of their consensus
binding sites, GGCCGCA for Lz (Kamachi et al., 1990; Xu et al., 2000) and
ATATCCGC for Pnt P2 (Xu et al., 2000). Interaction in absence of binding site
also establishes the fact that the interaction between the two proteins is not
mediated by their DNA-binding properties (Figure 18). Additionally, our
experiments indicate that an essential role in this interaction is played by the
alternatively spliced exon V of Lz.
Designing the mutant
Proteomic analysis of the alternatively spliced exon of Lz revealed two
important facts. First, a remarkable sequence identity among amino acids of the
alternatively spliced exon existed that was found to be conserved across species.
Second, structure prediction for this exon showed a prominent alpha helix
extending almost the entire length. Presence of such a strong secondary
structure for an alternatively spliced exon of a protein and conserved identity of
few amino acids among species leads us to believe that the helix must be
important in orchestrating the interaction with the Ets-1 protein. To test our
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hypothesis, I generated site directed mutation of conserved amino acids in the
alpha helix, creating a reversal of surface charge. The same mutation was also
incorporated in clone of just exon V. These lozenge clones were tested in
combination with Pnt P2.
The Lz-Pnt P2 concert: Utilizing the yeast
The yeast two-hybrid system first described by Fields and Song (1989) is
based on the modular nature of transcription factors, and provides a convenient
assay for studying protein-protein interactions. As it is performed in vivo it is not
limited by artificial conditions of in vitro assays like the electrophoretic mobility
shift assay (EMSA) and pull down experiments. In addition, sensitivity of the
yeast two-hybrid simplifies mutational analysis allowing investigations such as
mapping of motifs or residues required for interactions. Thus, in the present study
it not only provided a relevant biological system for detection, but it also enabled
us to evaluate the role of few crucial residues, and an alternatively spliced exon
of lozenge.
The crucial steps essential for the feasibility of the yeast two hybrid
involved a meticulous subcloning strategy. Lz and Pnt P2 were fused with
Activation Domain (AD) and DNA Binding Domain (DBD) of Gal4 transcription
factor carried by two shuttle vectors. Once generated, the clones were
sequenced to ensure that no PCR errors were introduced in this process and the
proteins were in-frame and in right orientation with its fusion partner.
Since the system is based on reconstitution of a functional factor, brought
together by the interacting fusion proteins, checking the auto-activation capacity
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of the target is crucial for overall success of the experiments. Single plasmid now
encoding the fusion proteins was used for transformation of yeast strain carrying
a UAS reporter lacZ gene responsive to the gal4 system. The yeast strain was
also auxotrophic for two amino acids Trp and Leu. Successful transformation was
evident by growth of colonies on media supplemented with the amino acid not
carried by plasmid. No lacZ activity was seen, in any of the single transformants
now carrying plasmids encoding fusion proteins-lozenge, pointed P2, lz exonV,
full-length lz mutant and Exon V mutant.
Previous work using yeast two hybrids suggests that a sequential
transformation strategy allows stable expression of the first protein, prior to
transformation with the second plasmid (Criekinge et al., 1999). This strategy
was followed in my first attempt and the second plasmid was introduced in the
single transformants in order to detect an interaction. These double
transformants grew on plates lacking both amino acids, indicating that both the
plasmids were present in the yeast. However, I failed to detect any reporter gene
activity in these double transformants. Why did I not see any activity? The
experiment introduces a runt homology-domain protein into yeast. Analysis of the
yeast genome indicates that yeast has no homologs for Runt or runt related
genes. (Adya et al., 2000) Presumably, by some undetermined mechanism, the
Lozenge expression is shut off but the plasmid can still overcome the auxotrophic
barrier and grow. Additionally, Lz shows some level of toxicity when expressed in
cell lines derived from both eukaryotes and prokaryotes (Personal
communication with Dr. Pollock). Evidentially, when yeast were transformed with
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Lz protein it interfered with normal yeast metabolism that may have given rise to
clones having spontaneous deletions in the plasmids that confers the yeast clone
a growth advantage. This would explain the fact that the even though the
colonies grew and looked normal they failed to show reporter gene activity. It
made the selectable marker fine however, it did not mean that the interaction was
occurring.
The failure of above experiments led me to try a different approach.
Similar studies with toxic proteins and yeast two hybrid had shown that co-
transformation works better than sequential transformation in these cases as it
alleviate some of the toxicity problems even though it yields significantly less
double-transformants (Criekinge et al., 1999). Utilizing this approach two distinct
sets of colonies were observed after the transformations. One set of colonies
grew similar in size and color to those obtained in sequential approach, while the
other set grew slower, were smaller than those in sequential transformation. This
observation corroborated the fact that Lz expression interferes with yeast
metabolism and hampers their growth. The smaller colonies were checked for
reporter gene activity and LacZ activity was detected in all double transformants
except the ones transformed with mutated lz exon 5 and pnt P2. Another
important difference noted from these different approaches is that an optimal
protein expression is observed in the growth phase of the newly transformed
yeast after which the spontaneous deletion process starts to occur, leading to
negative results. In other words it was essential to assay the colonies before the
toxicity starts to affect their growth and metabolism.
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The results of the co-transformation clearly demonstrated an interaction
between Lz and Pnt P2 proteins. Cell lysates from transformants were probed
with antibodies against the epitope tags expressed in fusion with the chimeric
proteins, confirming our results. The experiments also demonstrate that the
alternatively spliced exon has a functional significance and is essential for Lz-Pnt
P2 interaction. Interestingly, the full-length mutant lozenge also showed LacZ
activation however, mutated exon V alone failed to do so.
The results presented in this study explicitly prove that there is a physical
interaction between Lozenge and Pointed P2. Since this interaction occurs in the
absence of their DNA consensus binding sites it helps us to reject the earlier held
notion that interaction between the Runt-1 protein and Ets-1 protein occurs due
to their DNA binding ability. Lz exon V protein by itself showed interaction
suggesting that this spliced exon plays an essential role in this interaction.
In a related study on the mouse Runx1, PEBP protein that used EMSA,
Kim et al., showed two Ets-1 interacting domains in regions that include the
alternatively spliced exon. Results from this study add to their observation.
Positive results obtained with exon V in yeast two hybrid corroborate, that
alternatively spliced exon in Runt1 proteins have regions that are critical for their
interaction with Ets-1 proteins. It is interesting to note that the shorter isoforms;
LzD5 in Drosophila and PEPB 2aB2 in mouse still has only one of the two Ets-
1interacting regions identified in Kim et al. study. In their study, shift in
electrophoretic mobility of the DNA-protein combination was evident, but
significantly reduced, indicating the single Ets interacting domain is insufficient.
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The data I obtained from the Lz exon V mutated clone, which has an
altered charge residue on the helix, adds to this story. This alteration did not
overlap with the deduced Ets-1 interacting region contained in spliced exon V.
Mutation in full-length lozenge showed an interaction equivalent to non-mutated
Lz protein however, the same in just exon V failed to do so. This establishes the
fact that exon V and its secondary helix structure are essential for interaction,
and the two putative Ets-1 interacting regions help in stabilizing this interaction.
The fact the site of alternate splicing is found conserved from flies to
humans also raises the question of why nature would want to conserve this so
strictly, over several million years. A possible explanation can be drawn from
research conducted here. Given that the alternate splicing of exon V creates a
protein that is responsive to Ras MAPK activation of the Ets-1 factors.
Eliminating the Ets–1 interaction domain found in exon V of lz, creates a protein
that is responsive to the Ras MAPK activation of the Ets factors. Giving the
Runx1 family of proteins this capacity to enhances their capacity to function
within the complex roles of differentiation and proliferation. In case of Lozenge,
its early expression, which supports the survival of undifferentiated cells, is
independent of Ras MAPK activation of the Ets-1 factors. This expression of Lz
may employ the LzD5 splice variant. A few hours later in eye development, the
increased expression of Lz is dependent on the Ras MAPK activation of the Ets-
1 factors. Here it is expected that the full length Lz is expressed, permitting the
subsequent interaction of Lz with its Ets-1 transcription partner, Pnt P2. Future
experiments can support this hypothesis.
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Conclusions and Future studies
Lozenge proteins are clearly critical for cell differentiation during
development, and recent evidence shows that they also play important role in cell
survival (Siddall et al., 2003). Depending on the gene target, they can act as
activators or repressors (Crew et al., 1997). Previous research done in Pollock
lab showed that in parallel to Runx1 proteins, lz is alternatively spliced. This
finding helps to provide some insight into how these multiple roles may be
controlled during development. My own research strengthens the notion that
alternate splicing allows lz to contribute to these roles during differentiation and
proliferation.
Interestingly, AML1, Runx1 protein in humans has 11 isoforms and some
of them are known to have distinct roles in development. To this date only two
isoforms of lz have been identified but given the fact that Lz like AML1, is also
pleotropic hints that there may be other isoforms of lz.
My own mutant studies clearly show that lozenge exon V is essential for
interaction with Ets-1 protein. The next logical step is to generate new mutants to
enable us to identify whether the helical structure found in exon V is important for
this interaction or not. Inserting prolines in helix would produce a kink and
completely disturb the secondary structure of the exon. Generation of this mutant
will allow us to evaluate its role in the interacting with Ets-1. A second mutant,
currently begin developed in the Lab involves the truncation of amino acids that
make up the helix. The significance for probing the interaction regions for
proteins is underscored by the fact that the leukemogenic versions of AML1
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(humans) and Ets-1 bear mutations that should affect the regulation of DNA
binding and protein complex formation (Kim et al., 1999). Several translocation of
AML1 gene generating chimeric proteins, such as AML1/ETO and AML1/EVI-1
have been found in human myeloid leukemia, all of which cause a deletion of the
Negative regulatory domain and EII interaction surface (Ets interacting region, in
alternatively spliced exon) (Ito and Bae, 1997). Similarly, the viral version of Ets-1
contained in leukomogenic chicken virus E26 bears a mutation in inhibitory C-
terminal helix. It is also constitutively activated and does not require a cofactor for
DNA binding (Hagman et al., 1992; Lim et al., 1992). The escape from the
regulatory mechanisms that have evolved to tightly control the DNA binding
activity of these transcription factors may thus be major factor contributing to the
leukemogenic potential of their mutant versions. Thus generation of the mutant
along with the rich developmental genetic framework available in Drosophila
would makes an attractive system for furthering our knowledge on the structure,
function and developmental regulation of Runx1 family of proteins.
Surely, interaction of Lz protein is not restricted to Ets-1 protein. This is
also evident from evolutionarily conserved feature of the Runx family, namely,
their wide expression. This strongly suggests that Lz proteins are likely to interact
with other factors. It is therefore important that further studies on this aspect are
carried out by utilizing the existing Lz-yeast plasmid to screen a library prepared
from a tissue in which lz protein is known to be biologically relevant like the
antenna (smell), tarsal claw (taste), spermathecae etc. It will enable us to identify
and isolate novel associating proteins, thus elaborating our existing knowledge.
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Figure 18: Lz and Pnt P2 physically interact.
Yeast two hybrid analysis shows a physical interaction between Lz
(Runx1) and Pointed P2 (Ets-1) protein. In R7 photoreceptor Ras MAPK
activation leads to increased expression of Lz and phosphorylation of
Pointed P2 proteins, permitting their subsequent interaction. Lz and Pnt
P2 then bind to the prospero enhancer and mediate its transcription.
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